SCHEMBL344085

SCHEMBL344085

CCCCCCCCCCCCCCOCCO

nearest known ligand 0.95

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.95
KMT2A Q03164 4/20 0.95
HTT P42858 2/20 0.95
THRB P10828 1/20 0.95
MAPT P10636 1/20 0.95
TSHR P16473 3/20 0.80
USP2 O75604 2/20 0.54
MAPK1 P28482 2/20 0.53
LMNA P02545 3/20 0.52
ALDH1A1 P00352 3/20 0.52
HSD17B10 Q99714 1/20 0.52
CES2 O00748 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.49
CYP3A4 P08684 1/20 0.49
CASP1 P29466 1/20 0.49
SLCO1B3 Q9NPD5 1/20 0.49
SLCO1B1 Q9Y6L6 1/20 0.49
CES1 P23141 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6138568 1.00 MEN1 (0.95) MEN1KMT2AHTTTHRBMAPT
SCHEMBL21828760 1.00 MEN1 (0.95) MEN1KMT2AHTTTHRBMAPT
Di(Hydroxyethyl)Ether SCHEMBL2484145 1.00 MEN1 (0.95) MEN1KMT2AHTTTHRBMAPT
Di(Hydroxyethyl)Ether SCHEMBL23356733 1.00 MEN1 (0.95) MEN1KMT2AHTTTHRBMAPT
Di(Hydroxyethyl)Ether SCHEMBL23356816 1.00 MEN1 (0.95) MEN1KMT2AHTTTHRBMAPT
Di(Hydroxyethyl)Ether SCHEMBL23356871 1.00 MEN1 (0.95) MEN1KMT2AHTTTHRBMAPT
Di(Hydroxyethyl)Ether SCHEMBL23356793 1.00 MEN1 (0.95) MEN1KMT2AHTTTHRBMAPT
Di(Hydroxyethyl)Ether SCHEMBL23356787 1.00 MEN1 (0.95) MEN1KMT2AHTTTHRBMAPT
SCHEMBL185805 1.00 MEN1 (0.95) MEN1KMT2AHTTTHRBMAPT
Di(Hydroxyethyl)Ether SCHEMBL2124090 1.00 MEN1 (0.95) MEN1KMT2AHTTTHRBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1463 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4117622-B1 NEW USE AND METHOD OF TREATMENT HUNTER CAPITAL AB PUBL (SE) 2026-05-20 EP claimed
US-20260108445-A1 CREAMY SILICONE AND SULFATE-FREE CONDITIONING SHAMPOO L'OREAL (FR) 2026-04-23 US claimed
EP-3872118-B1 PREPARATION METHOD OF SUPER ABSORBENT POLYMER LG CHEMICAL LTD (KR) 2026-04-01 EP claimed
US-20260060240-A1 METHOD OF DEPRESSING VOLATILITY OF ORGANIC SOLUTES FROM THEIR AQUEOUS SOLUTIONS VIVE CROP PROT INC (CA) 2026-03-05 US claimed
WO-2025229061-A1 COMPOSITION FOR ANTI-GRAFFITI COATING AND METHOD FOR PREPARING THE COMPOSITION O2-TABS DESINFEKTION GMBH (DE) 2025-11-06 WO claimed
US-20250213512-A1 TRANSDERMAL ANALGESIC FORMULATION AUSTRALIAN MEAT & LIVE STOCK (AU) 2025-07-03 US claimed
WO-2025102195-A1 COMPOSITION FOR CARING FOR KERATIN MATERIALS L'OREAL (FR) 2025-05-22 WO claimed
WO-2025096803-A1 MINOXIDIL ADJUVANT THERAPIES CARING BRANDS, INC. (US) 2025-05-08 WO claimed
US-12280027-B2 Transdermal analgesic formulation MEAT & LIVESTOCK AUSTRALIA LTD (AU) 2025-04-22 US claimed
CN-119638787-A Hair loss preventing shampoo containing active peptide 北京鸿宇达生物科技有限公司 2025-03-18 CN claimed
EP-1765260-A2 SANITIZING COMPOSITION AND METHOD OF PREPARATION Brown, Steven J. (US) 2007-03-28 EP claimed
WO-2006085907-A2 SANITIZING COMPOSITION AND METHOD OF PREPARATION BROWN STEVEN J (US) 2006-08-17 WO claimed
US-20050271595-A1 Sanitizing composition and method of preparation BROWN JAMES S 2005-12-08 US claimed
US-6616922-B2 For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user THE DIAL CORPORATION 2003-09-09 US claimed
US-20030022941-A1 For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user Henkel IP & Holding GmbH (DE) 2003-01-30 US claimed
WO-2002076207-A1 ANTIBACTERIAL COMPOSITIONS THE DIAL CORPORATION (US) 2002-10-03 WO claimed
EP-0862433-B1 TOPICAL FOAMABLE PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISEASES INDUCED BY OVAL PITYROSPORUM PF MEDICAMENT (FR) 2002-09-11 EP claimed
EP-0862433-A1 TOPICAL FOAMABLE PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISEASES INDUCED BY OVAL PITYROSPORUM PIERRE FABRE MEDICAMENT (FR) 1998-09-09 EP claimed
WO-1997017075-A1 TOPICAL FOAMABLE PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISEASES INDUCED BY OVAL PITYROSPORUM PIERRE FABRE MEDICAMENT (FR) 1997-05-15 WO claimed
US-5290555-A Water, alcohol mixtures or water, alcohol, oil mixtures REVLON CONSUMER PRODUCTS CORPORATION (US) 1994-03-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260108445-A1 CREAMY SILICONE AND SULFATE-FREE CONDITIONING SHAMPOO SMURF1, SGMS1, SGMS2 MEN1 3153/4885KMT2A 3084/4885HTT 2200/4885
US-20260060240-A1 METHOD OF DEPRESSING VOLATILITY OF ORGANIC SOLUTES FROM THEIR AQUEOUS SOLUTIONS MYB, DRD1, SFN MEN1 4484/4885KMT2A 2694/4885HTT 2253/4885
US-20030022941-A1 For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user CUTA, CHIT1, CLSPN MEN1 2997/4885KMT2A 1416/4885HTT 3893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.